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Introduction: Based on the potential interest in sodium lactate as an energy substrate and resuscitative fluid,
we investigated the effects of hypertonic sodium lactate in a porcine endotoxic shock.
Methods: Fifteen anesthetized, mechanically ventilated pigs were challenged with intravenous infusion of
E. coli endotoxin. Three groups of five animals were randomly assigned to receive 5 mL/kg/h of different fluids: a
treatment group received hypertonic sodium lactate 11.2% (HSL group); an isotonic control group receiving 0.9%
NaCl (NC group); a hypertonic control group with the same amount of osmoles and sodium than HSL group
receiving hypertonic sodium bicarbonate 8.4% (HSB group). Hemodynamic and oxygenation variables, urine output
and fluid balance were measured at baseline and at 30, 60, 120, 210 and 300 min. Skin microvascular blood flow at
rest and during reactive hyperemia was obtained using a laser Doppler flowmetry technique. Results were given as
median with interquartile ranges.
Results: Endotoxin infusion resulted in hypodynamic shock. At 300 min, hemodynamics and oxygenation were
significantly enhanced in HSL group: mean arterial pressure (103 [81–120] mmHg vs. 49 [41–62] in NC group vs.
71 [60–78] in HSB group), cardiac index (1.6 [1.2–1.8] L/min/m2 vs. 0.9 [0.5–1.1] in NC group vs. 1.3 [0.9–1.6] in HSB
group) and partial pressure of oxygen (366 [308–392] mmHg vs. 166 [130–206] in NC group vs. 277 [189–303]
in HSB group). At the same time, microvascular reactivity was significantly better in HSL group with a lower
venoarterial CO2 tension difference (5.5 [4–10] mmHg vs. 17 [14–25] in NC group vs. 14 [12–15] in HSB group).
The cumulative fluid balance was lower in HSL group (-325 [-655; -150] mL) compared to NC (+560 [+230; +900] mL,
p = 0.008) and HSB (+185 [-110; +645] mL, p = 0.03) groups.
Conclusions: In our hypodynamic model of endotoxic shock, infusion of hypertonic sodium lactate improves
hemodynamic and microvascular reactivity with a negative fluid balance and a better oxygenation.Introduction
Sepsis, the syndrome of microbial infection complicated
by systemic inflammation, is a major public health prob-
lem associated with significant morbidity and mortality
[1,2]. Due to constant hypovolemia, fluid resuscitation is a
cornerstone of septic shock management [3]. Indeed, early
fluid therapy is common in patients with septic shock [4].
Both adequate initial fluid resuscitation and conservative
late fluid management could improve patient outcome [5].
In fact, excess fluid could be deleterious [6], and negative
fluid balance has been shown to be associated with better* Correspondence: mercedes.jourdain@univ-lille2.fr
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unless otherwise stated.survival rates [7], especially in acute lung injury [8,9], and
acute kidney injury [10]. Although adequate fluid resusci-
tation is commonly acknowledged as an important elem-
ent in the treatment of patients with septic shock, the
choice of resuscitation fluid remains a point of discussion.
The 2012 Sepsis Surviving Campaign guidelines recom-
mend crystalloids as the initial fluid of choice for resusci-
tation in severe sepsis and septic shock [11]. Isotonic
saline (0.9% sodium chloride) is the most commonly used
fluid [12]. Nevertheless, in order to avoid excess fluid, the
concept of small volume resuscitation with hypertonic
saline solute has been well-received. Low volume of
hypertonic fluids may have valuable effects on restoration
of intravascular volume (fluid shifts from the intracellular
to the extracellular compartment), on improvement ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ment of regional microcirculation without fluid overload
[14]. However, with the potentially beneficial sodium
cation, the presence of non-metabolized chloride anion
may have detrimental effects. Supraphysiological concen-
trations of chloride, which induce hyperchloremia and
metabolic acidosis, may cause renal vasoconstriction and
decreased glomerular filtration rate [15]. Moreover, in a
recent study, a chloride-restrictive strategy in intensive
care units was associated with a significant decrease in the
incidence of acute kidney injury and in the use of renal
replacement therapy [16]. Hence, in an attempt to avoid
the detrimental effects of non-metabolized anion, the use
of metabolized anions such as lactate may be required.
The use of lactate is an interesting alternative because this
anion is well-metabolized [17] even in poor hemodynamic
conditions [18]. Some positive clinical experience in using
sodium lactate is available. In cardiac surgery, exogenous
lactate has been shown to improve cardiac index and has
been shown to be safe and well-tolerated [19]. Lactate
may serve as a resuscitation fluid-based energetic sub-
strate providing a high-octane fuel [20] to improve heart
performance [19,21], and simultaneously to normalize
fluid balance [14,21]. There are no data available on the
administration of hypertonic sodium lactate in sepsis or
septic shock. Based on the potential interest in sodium-
lactate as an energy substrate and resuscitative fluid, we
investigated the effects of hypertonic sodium lactate on
fluid balance, hemodynamic and microcirculation in a
porcine model of endotoxic shock.
Materials and methods
We performed a prospective, randomized, controlled
experimental study approved by the Institutional Review
Board for Animal Research (protocol CEEA 132012); care
and handling of the animals were in accordance with
National Institutes of Health guidelines.
Animal preparation
Fifteen adult female Large White pigs (2 months old)
were used in this study. For the experiment, animals were
premedicated with intramuscular injection of ketamine
(Kétalar®, Virbac, Vauvert, France, 2.5 mg/kg of body
weight) and xylazine (Sédaxylan®, CEVA Santé Animale,
Libourne, France, 2.5 mg/kg of body weight). Then we used
Isoflurane (Aerrane®, Baxter, Maurepas, France) for the in-
tubation process, and maintenance of anesthesia was
performed with a continuous infusion of midazolam
(Hypnovel®, Roche, Neuilly, France, 1 to 2 mg/kg body
weight/h) for the whole experiment. Animals were mechan-
ically ventilated (Osiris 2®, Taema, Antony, France) with a
tidal volume 10 mL/kg, positive end-expiratory pressure 3
cmH2O to limit cardiovascular effects, inspired oxygen
fraction (FiO2) 0.6 to prevent fatal hypoxemia during thestudy, respiratory rate 14 to 20 breaths/minute only ad-
justed to have normocapnia (40 to 45 torr) at baseline. We
chose to maintain similar ventilation in all animals during
the experiment. No recruitment maneuvers were done.
Muscle relaxation was obtained by a continuous infusion of
cisatracurium besylate (Nimbex®, Hospira, Meudon, France,
2 mg/kg body weight/h). Analgesia was achieved by a
subcutaneous injection of buprenorphine (Vetergesic®,
Sogeval, Laval, France, 0.1 mg/kg body weight). Subcuta-
neous administration of buprenorphine in our animals is
known to permit analgesia during six to eight hours. After
dissection of neck vessels, catheters were inserted in the
pulmonary artery via the right external jugular vein
(Swan-Ganz; Baxter 110 H 7.5 F; Baxter Edwards Critical
Care, Irvine, CA, USA) and in the right carotid artery for
continuous blood pressure monitoring and blood sam-
pling. To monitor urine output, a suprapubic urinary
catheter was inserted by laparotomy. An esophageal
temperature probe measured core temperature.
Macrocirculatory and oxygenation parameters
Systemic arterial and venous blood samples from carotid
and pulmonary arteries were obtained simultaneously. Ar-
terial and venous blood gas tensions and lactate levels were
measured in an acid-base analyzer (ABL-800, Radiometer,
Copenhagen, Denmark). Blood oxygen content was calcu-
lated from the hemoglobin content and oxygen saturation.
Heart rate, systemic and pulmonary arterial pressures
were continuously monitored (90308 PC Express Portable
Monitor, Spacelabs, Snoqualmie, WA, USA) as well as
cardiac output and mixed venous oxygen saturation
(Vigilance monitor; Baxter Edwards, Irvine, CA, USA).
Using standard formulae we computed global oxygen deliv-
ery (DO2), global oxygen consumption (VO2), oxygen ex-
traction ratio (OER), cardiac index (L/min/m2), cardiac
power index (CPI) (W/m2) [22], systemic vascular resist-
ance (SVR) and pulmonary vascular resistance (PVR)
(dynes/sec/cm5). Body surface area was calculated by
Kelley’s formula [23].
Study design
The study was carried out as depicted in Figure 1. During
the preparation period, animals received 25 mL/kg 0.9%
NaCl to prevent hypovolemia. When all preparations were
completed, a 30-minute period was allowed to stabilize
the measured variables. Macrocirculatory measurements
were taken over a 5-h period: two times at baseline (before
(T) and after (T0) the stabilization period) and at 30
(T30), 60 (T60), 120 (T120), 210 (T210) and 300 (T300)
minutes. Arterial and venous blood gas tensions and lac-
tate levels were collected at the same time (except T
and T30) until the study was completed. After anesthesia,
catheterization, and baseline collection (T0), all ani-
mals were administered 5 μg/kg/min Escherichia coli
Preparation 
T120 T60 T30 T210 T300 T 
LPS (5 γ/kg/min) 
T0 
NaCl 0.9% 25 mL/kg 
NaCl 0.9% / HSL / HSB 
5 mL/kg/h from T30 to T300 
HR, BP, PBP, PCWP, SvO2, CI measurements 
Laser Doppler flowmetry measurements 
(2.5 mL/kg/15 min of NaCl to maintain MAP ≥ 50 mmHg) 
Stabilisation 
A-VBG, lactate and glucose levels + urine output 
Figure 1 Study design. During the preparation period, animals received 25 mL/kg 0.9% NaCl to prevent hypovolemia. When preparation was
completed, a 30-minute period served to stabilize the measured variables. Measurements were taken over a 5-h period. Throughout the duration
of the experiment, heart rate (HR), blood pressure (BP), pulmonary blood pressure (PBP), pulmonary capillary wedge pressure (PCWP), mixed
venous oxygen saturation (SvO2), cardiac index (CI) and laser Doppler flowmetry measurements were recorded. Arterial and venous blood gas
(A-VBG) was collected at the same time (except T and T30) until the study was completed. Animals were infused with 5 μg/kg/min of Escherichia
coli lipopolysaccharide (LPS) from T0 to T30. We studied three groups of five animals receiving 5 mL/kg/h of different fluids: 0.9% NaCl (NC group),
hypertonic sodium bicarbonate 8.4% (HSB group) and hypertonic sodium lactate 11.2% (HSL group). If mean arterial pressure (MAP) felt below
50 mmHg, a 2,5 mL/kg infusion of NaCl 0.9% was given as rescue therapy every 15 minutes. Bolus infusions were performed to maintain mean
arterial pressure (MAP) above 50 mmHg.
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ical Co., St. Louis, MO, USA). The endotoxin was diluted
in 50 mL of 0.9% NaCl and infused intravenously over a
30-minute period. Our model was of hypodynamic shock
with low level resuscitation. The only resuscitation end-
point was mean arterial pressure (MAP). We studied three
groups of five animals receiving 5 mL/kg/h (from T30 to
T300) of different fluids: two control groups, receiving
0.9% NaCl (NC group), 8.4% hypertonic sodium bicarbon-
ate (HSB group) containing 61 g of bicarbonate and 23 g
of sodium per liter and a treatment group receiving 11.2%
hypertonic sodium lactate AP-HP® (AGEPS, Paris, France)
(HSL group) containing 90 g of lactate and 23 g of sodium
per liter (Additional file 1). Hypertonic groups (HSB and
HSL groups) provided the same amount of sodium and os-
moles (2,000 mosm/L). If MAP fell below 50 mmHg, a 2.5-
mL/kg infusion of NaCl 0.9% was given as rescue therapy
every 15 minutes. Bolus infusions were performed to main-
tain MAP above 50 mmHg.
Microcirculatory parameters
Skin microvascular blood flow was measured continu-
ously using a laser Doppler flowmeter probe and device
(Periflux® PF407; Perimed, Jiirfalla, Sweden). The blood flow
was measured in a volume of 1 mm3 solid tissue. The fiber
optic probe was applied on the right hind paw of the ani-
mals and fixed with adhesive tape. Laser Doppler signal was
continuously registered on a personal computer. Readjust-
ing the pen of the recorder to zero when the probe was
fixed to a white non-moving surface performed flux zero
calibration. Skin blood flow was measured at rest and dur-
ing reactive hyperemia from T0 to T300, and values
were expressed in arbitrary perfusion units (PU). Reactivehyperemia was produced by arrest of leg blood flow with
a pneumatic cuff inflated to a suprasystolic pressure
(200 mmHg) for 3 minutes. On completion of the ischemic
period, the occluding cuff was rapidly deflated to zero.
Peak flow was defined as the highest flow signal during
the post occlusive phase. Reactive hyperemia was further
analyzed (Perisoft® 2.5 software) according to its duration
and initial reactive hyperemia uphill slope.
Biological methods and fluid balance
During the study, capillary glucose (Accu-Chek PER-
FORMA®, Roche Diagnostics SAS, Meylan, France) was
measured at T0, T60, T120, T210 and T300. Other vari-
ables included arterial serum and urinary electrolyte con-
centrations, urea, creatinine and measured osmolalities.
Apparent strong ion difference (SID) was calculated as:
((Na+ + K+ + Ca2+ + Mg2+) – (Cl- + Lactate-)) [24].
Variables were recorded at T0 and T300. At the end of
the study, sodium and chloride balance was determined
by calculating for each individual the difference between
the cumulative amounts of electrolytes administered
from T210 to T300 and the cumulative amounts of elec-
trolytes collected in the urine during the same period. We
also computed urea and creatinine clearance with stand-
ard formulas. Urine output was measured at T0, T60,
T120, T210 and T300. Fluid balance from T0 to T300 was
determined by calculating the difference between the
cumulative amounts of fluids administered and the cumu-
lative amounts of fluids collected in the urine.
Data analysis
Statistical analysis was performed with GraphPad Prism 6
software. As the distribution was not normal (Shapiro-Wilk
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interquartile range. For multiple intergroup testing, we used
the Kruskal-Wallis test with the Dunn multiple com-
parisons test and the Mann-Whitney U-test. Intragroup
comparisons were performed using the Friedman test with
the Dunn multiple comparisons test. A P-value <0.05 was
considered significant.
Results
The fifteen studied animals were divided into three
groups. Median weight was similar in the three groups
of animals: 21 (19.25 to 22.75) kg in the NC group, 21
(19.75 to 22.5) kg in the HSB group and 22 (20.75 to
22.5) kg in the HSL group.
Evolution of lactate levels
Lactate levels (Additional file 2) were comparable at base-
line between the three groups (0.7 (0.7 to 0.8) mmol/L).
During the study, we observed a similar increase of lactate
levels in both control groups. At 300 minutes, lactate
levels were 5.5 (3.8 to 8) mmol/L in the NC group and 4.2
(3.2 to 7.9) mmol/L in the HSB group. In the HSL group,
however, lactate levels increased earlier. At 60 minutes,
lactate level was 9.7 (9.3 to 14) mmol/L and then re-
mained stable until the end of the study. Compared with
control groups, lactate levels were significantly higher in
the HSL group from T60 to T300 (P <0.0001).
Macrocirculatory parameters
Changes in HR, MAP, CI, mean pulmonary arterial pres-
sure (MPAP), mixed venous oxygen saturation (SvO2),
oxygen extraction (EO)2, DO2/VO2 ratio and Pv-aCO2
are illustrated in Figures 2 and 3. Variations in right
atrial pressure (RAP), pulmonary capillary wedge pres-
sure (PCWP) and CPI are presented in Additional file 2.
No changes in studied variables were observed during
stabilization period and no differences were observed
among groups. Endotoxin infusion resulted in similar
and usual changes in hemodynamics until 60 minutes as
previously described [25,26]. Thereafter, better hemody-
namic stability was observed in the HSL group. At
300 minutes, MAP returned to the baseline level in
the HSL group while a 51% and 30% decrease was ob-
served respectively in the NC and HSB groups. Through-
out the study, six animals (three in the NC group, two in
the HSB group and only one in the HSL group) required
0.9% NaCl boluses to maintain MAP ≥50 mmHg accord-
ing to the study protocol. SVR changes were similar in the
three groups without any significant differences. CI im-
pairment, at 300 minutes, was less pronounced in the
HSL group (1.6 (1.2 to 1.8) L/min/m2) compared to BS
(1.3 (0.9 to 1.6), P = 0.53) and NC (0.9 (0.5 to 1.1),
P = 0.01) groups. Finally, compared to control groups, CPI
was significantly better from 120 to 300 minutes in theHSL group. With regard to lung function, we observed a
similar increase (60% compared to baseline) in MPAP
30 minutes after the infusion of endotoxin in the three
groups, then MPAP decreased at 60 minutes. From 120 to
210 minutes, the increase in MPAP was significantly more
important in the NC group compared with the hypertonic
groups. DO2 decreased in the three groups between 60 and
300 minutes. Compared with hypertonic groups, this de-
crease was significantly more pronounced in the NC group
from 210 to 300 minutes. At the same time, VO2 increased
in the three groups without significant differences, resulting
in increased EO2 in the three groups. Compared to the
hypertonic groups, this EO2 increase was significantly more
important in the NC group from 210 to 300 minutes. In
parallel, SvO2 decreased from baseline to 300 minutes
by 56% in the NC group, 18% in the HSB group and 9% in
the HSL group. They were no significant differences be-
tween the hypertonic groups in DO2, EO2 and SvO2
changes. Nevertheless, venoarterial CO2 tension difference
(P(v-a)CO2) was larger in the HSB group (14 (12 to 15))
than in the HSL group (5.5 (4 to 10), P = 0.01).
Microcirculatory parameters
Changes in occlusive areas (AO) and hyperemic areas
(AH) are illustrated in Figure 4. Occlusive areas (AO),
hyperemic areas (AH), rest flow (RF) and peak flow (PF)
were similar at baseline between the three groups. During
the study period, all these variables decreased significantly
in the NC group and increased significantly in the HSL
group. No significant variations were observed in the HSB
group. At the end of the study (300 minutes), RF and PF
were better in the HSL group (33 (22 to 40) PU and 58
(50 to 84) PU respectively) compared to the NC (8 (7 to
11) PU; P = 0.01 and 15 (14 to 17) PU; P = 0.01 respect-
ively) and HSB groups (18 (13 to 23) PU; P = 0.03 and 37
(30 to 39) PU; P = 0.01 respectively). In the same way, AO
and AH at 300 minutes were more important in the HSL
group (3,200 (2,300 to 6,800) PU × sec and 2,300 (700 to
3,500) PU × sec respectively) compared to the NC (270
(120 to 370) PU × sec; P = 0.01 and 110 (31 to 200) PU ×
sec; P = 0.01 respectively) and HSB groups (600 (200 to
1,300) PU × sec; P = 0.04 and 800 (300 to 1,400) PU × sec;
P = 0.15 respectively).
Urine output and fluid balance
Total vascular filling, urine output, fluid balance and the
variations in arterial oxygen partial pressure and inspired
oxygen fraction (PaO2/FiO2) ratio are illustrated in
Figure 5. Urine output and fluid balance at baseline
were similar among groups. From 120 to 300 minutes,
significantly higher urine output was noticed in the
HSL group compared to control groups, resulting in
a significantly lower fluid balance. PaO2/FiO2 ratio de-
creased in the three groups. Compared to control groups,
Figure 3 Changes in mixed venous oxygen saturation (SvO2), oxygen extraction (EO2), DO2/VO2 ratio and venoarterial CO2 tension
difference (Pv-aCO2). Open circles and dotted line: 0.9% NaCl (NC) group (n = 5); squares and gray line: hypertonic sodium bicarbonate (HSB)
group (n = 5); closed circles and black line: hypertonic sodium lactate (HSL) group (n = 5). Results are expressed as median with interquartile
range. When not displayed, error bars are within the symbols. *P <0.05, NC versus HSL; #P <0.05, HSB versus HSL; °P <0.05, NC versus HSB.
Figure 2 Changes in heart rate (HR), mean arterial pressure (MAP), cardiac index (CI) and mean pulmonary arterial pressure (MPAP).
Open circles and dotted line: 0.9% NaCl (NC) group (n = 5); squares and gray line: hypertonic sodium bicarbonate (HSB) group (n = 5); closed
circles and black line: hypertonic sodium lactate (HSL) group (n = 5). Results are expressed as median with interquartile range. When not
displayed, error bars are within the symbols. *P <0.05, NC versus HSL; #P <0.05, HSB versus HSL; °P <0.05, NC versus HSB.
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Figure 4 Variations in occlusive areas (AO) and hyperaemic areas (AH). Open circles and dotted line: 0.9% NaCl (NC) group (n = 5); squares
and gray line: hypertonic sodium bicarbonate (HSB) group (n = 5); closed circles and black line: hypertonic sodium lactate (HSL) group (n = 5).
Results are expressed as median with interquartile range. When not displayed, error bars are within the symbols. *P <0.05, NC versus HSL;
#P <0.05, HSB versus HSL; °P <0.05, NC versus HSB. PU, perfusion units.
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HSL group. Median values of PaO2/FiO2 at 300 minutes
were 366 (308 to 392) mmHg in the HSL group versus
277 (189 to 303) (P = 0.03) in HBS group and 166 (130 to
206) (P = 0.01) in the NC group.
Biological parameters
The evolution of biological parameters during the study
is presented in Table 1. In the NC group, urine tests
were not performed at 300 minutes because all animalsFigure 5 Total vascular filling, urine output, fluid balance from time z
oxygen partial pressure and inspired oxygen fraction ratio (PaO2/FiO2
and gray line: hypertonic sodium bicarbonate (HSB) group (n = 5); closed c
Results are expressed as median with interquartile range. When not display
#P <0.05, HSB versus HSL; °P <0.05, NC versus HSB.were anuric. Biological parameters were comparable at
T0 between the three groups.
Acid-base status
Arterial pH and bicarbonate levels decreased over time
(P <0.01 at 300 minutes) in the NC group. Contrarily,
these variables levels increased over time in the hypertonic
groups (P <0.001 at 300 minutes) without any differences
between the HSB and HSL groups. Compared to the NC
group, pH and bicarbonate levels were significantly higherero (T0) to time 300 minutes (T300) and variations in arterial
). Open circles and dotted line: 0.9% NaCl (NC) group (n = 5); squares
ircles and black line: hypertonic sodium lactate (HSL) group (n = 5).
ed, error bars are within the symbols. *P <0.05, NC versus HSL;












NC versus NC versus HSB versus
HSB HSL HSL
BLOOD
Lactate, mmol/L T0 0.7 (0.5 to 0.8) 0.65 ( 0.6 to 0.7) 0.7 (0.7 to 0.8) ns ns ns
T210 3.9 (2.7 to 6.9) 3.7 (2.8 to 4.7) 11.8 (10.5 to 17.7) ns 0.01 0.01
T300 5.5 (3.8 to 8.0) 4.2 (3.2 to 7.9) 11.8 (10.3 to 16.0) ns 0.01 0.01
pH T0 7.45 (7.39 to 7.48) 7.44 (7.38 to 7.47) 7.43 (7.41 to 7.48) ns ns ns
T210 7.23 (7.21 to 7.26) 7.45 (7.37 to 7.50) 7.50 (7.46 to 7.53) 0.01 0.01 ns
T300 7.20 (7.17 to 7.24) 7.47 (7.42 to 7.52) 7.52 (7.47 to 7.55) 0.01 0.01 ns
HCO3-, mmol/L T0 29 ( 28 to 32) 29 (28 to 31) 30 (28 to 31) ns ns ns
T210 22 (20 to 26) 48 (44 to 52) 49 (46 to 54) 0.01 0.01 ns
T300 19 (15 to 25) 54 (48 to 59) 55 (51 to 58) 0.01 0.01 ns
PaCO2, mmHg T0 43 (41 to 47) 44 (40 to 49) 45 (41 to 48) ns ns ns
T210 50 (44 to 53) 65 (49 to 67) 58 (49 to 63) ns ns ns
T300 52 (47 to 59) 70 (62 to 73) 62 (57 to 68) ns ns ns
Urea, g/L T0 0.18 (0.13 to 0.21) 0.16 (0.13 to 0.19) 0.14 (0.11 to 0.20) ns ns ns
T300 0.34 (0.28 to 0.42) 0.30 (0.26 to 0.34) 0.18 (0.13 to 0.23) ns 0.02 0.02
Creatinine, mg/L T0 9.0 (7.5 to 10.0) 7.0 (6.0 to 8.5) 7.0 (6.5 to 8.5) ns ns ns
T300 16.0 (13.5 to 17.5) 10.0 (9.5 to 14.5) 11.0 (10.0 to 12.0) 0.04 0.02 ns
Na+, mmol/L T0 140 (137 to 145) 142 (138 to 146) 137 (138 to 140) ns ns ns
T300 142 (138 to 146) 164 (161 to 166) 162 (158 to 164) 0.01 0.01 ns
K+, mmol/L T0 4.0 (3.9 to 4.1) 3.9 (3.5 to 4.3) 3.9 (3.7 to 4.0) ns ns ns
T300 4.9 ( 4.6 to 5.4) 3.7 (3.5 to 3.9) 3.5 (3.3 to 3.6) 0.01 0.01 ns
Cl-, mmol/L T0 101 (98 to 107) 101 (100 to 105) 100 (99 to 101) ns ns ns
T300 106 (103 to 115) 98 (96 to 101) 93 (91 to 96) 0.02 0.01 0.02
Ca2+, mmol/L T0 2.48 (2.37 to 2.51) 2.55 (2.31 to 2.59) 2.45 (2.37 to 2.57) ns ns ns
T300 2.1 (1.8 to 2.2) 1.9 (1.8 to 2) 2.0 (1.9 to 2.2) ns ns ns
Mg2+, mmol/L T0 0.75 (0.70 to 0.80) 0.68 (0.64 to 0.73) 0.70 (0.68 to 0.77) ns ns ns
T300 1.0 (0.9 to 1.1) 0.74 (0.66 to 0.88) 0.70 (0.64 to 0.80) 0.02 0.02 ns
SID, mEq/L T0 45 (42 to 47) 44 (39 to 45) 45 (44 to 46) ns ns ns
T300 36 (32 to 41) 67 (60 to 70) 64 (61 to 68) 0.01 0.01 ns
Osmolality, mosm/kg T0 294 (289 to 304) 290 (286 to 295) 293 (286 to 296) ns ns ns
T300 302 (295 to 308) 337 (335 to 342) 341 (338 to 345) 0.01 0.01 ns
URINE
Na+, mmol/L T0 131 (78 to 150) 91 (69 to 150) 95 (84 to 110) ns ns ns
T300 111 (90 to 156) 183 (169 to 190) 0.03
K+, mmol/L T0 22.3 (16.6 to 38.6) 15.3 (9.3 to 32.9) 23.4 (13.6 to 28.8) ns ns ns
T300 24.6 (13.1 to 36.2) 15.2 (10.7 to 17.9) ns
Cl-, mmol/L T0 157 (64 to 183) 125 (64 to 197) 98 (83 to 137) ns ns ns
T300 49 (31 to 55) 51 (46 to 52) ns
Osmolality, mosm/kg T0 543 (309 to 683) 475 (339 to 576) 394 (252 to 468) ns ns ns
T300 366 (328 to 377) 378 (362 to 383) ns
Results are expressed as median with interquartile range. Mann-Whitney U-test was used for intergroup comparisons; P <0.05 was considered significant. Urine tests
were not performed at 300 minutes in the NC group because all animals were anuric. SID, apparent strong ion difference ((Na+ + K+ + Ca2+ + Mg2+) – (Cl- + Lactate-)).
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Figure 6 Variations in blood glucose levels. Open circles and
dotted line: 0.9% NaCl (NC) group (n = 5); squares and gray line:
hypertonic sodium bicarbonate (HSB) group (n = 5); closed circles
and black line: hypertonic sodium lactate (HSL) group (n = 5). Results
are expressed as median with interquartile range. When not displayed,
error bars are within the symbols. *P <0.05, NC versus HSL #P <0.05;
HSB versus HSL; °P <0.05, NC versus HSB.
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The partial pressure of carbon dioxide increased in
the three groups over time without any significant
differences.
Electrolyte balance and renal function
Sodium and chloride intake, from 210 to 300 minutes,
was comparable in the HSB and HSL groups. However
sodium and chloride output was higher in the HSL
group (50 (17 to 77) and 13 (5 to 20) mmol respectively)
compared to the HSB group (1.1 (0.4 to 12) mmol, P = 0.02
and 0.4 (0.3 to 3.2) mmol, P = 0.004 respectively), thus
resulting in significantly lower sodium and chloride bal-
ances in the HSL group. Urea and creatinine clearance was
also significantly higher in the HSL group (40 (13 to 52)
and 51 (27 to 79) mL/minute) compared to the HSB group
(4 (1 to 11) and 12 (3 to 24) mL/minute, P = 0.01 and 0.03
respectively).
Blood glucose levels
We observed a significant decrease in both control groups
while it remained stable in the HSL group (Figure 6). At
300 minutes, blood glucose levels were significantly higher
in the HSL group (0.62 (0.53 to 0.78) g/L) compared to
the NC (0.27 (0.12 to 0.39) g/L, P = 0.01) and HSB (0.20
(0.16 to 0.29) g/L, P = 0.01) groups.
Discussion
We report here that the infusion of HSL solution im-
proves hemodynamic stability and microvascular reactivity
with a negative fluid balance and better oxygenation. This
was the first time that HSL was investigated in large
endotoxic animals. Pigs were chosen as a clinically rele-
vant species, resembling humans in various functions as
assessed by cardiovascular, respiratory, and biochemical
parameters [27]. In order to maximize the potential bene-
ficial effects of HSL, we deliberately investigated its impact
in the worst hemodynamic conditions associated with
sepsis. In fact, our model was that of hypodynamic shock
with low-level resuscitation. We used a low rate of
vascular filling to maintain MAP ≥50 mm Hg rather than
keeping the volume constant and allowing pressures to
vary. Our purpose was to compare HSL with two different
therapeutic regimens: a standard fluid therapy with iso-
tonic crystalloids (0.9% NaCl, the most commonly used
crystalloid) and a non-conventional hypertonic fluid
therapy with the same amount of osmoles and sodium.
Due to an acidifying effect on pH and an elevated chloride
concentration, hypertonic saline was not close enough to
HSL. We decided that the best hypertonic control was
HSB. In fact, HSB does not contain a chloride cation
and has the same alkaline effect on blood pH as HSL
(see Table 1). On HSL infusion, lactate is metabolized
and the remaining Na+ increases the SID, leading in turnto decreased water dissociation and proton concentration,
resulting in an alkalinizing effect [24]. Thereby, the main
difference between hypertonic solutions was the potential
role of lactate as an energetic substrate.
The hemodynamic results of our study were consistent
with a favorable effect of hypertonic solutions. An ex-
planation could be the larger amount of sodium, which
regulated extracellular volume, in the hypertonic groups.
This is in good agreement with data from the literature
[28,29]. Potential advantages of hypertonic fluid admin-
istration rather than isotonic solutions have already been
described in shock [30]. High extracellular sodium con-
centration could favor a reverse mode of Na+-Ca2+ ex-
changer to induce a positive inotropic effect [31]. These
hemodynamic improvements were more marked in the
HSL compared to the HSB group. MAP in the HSL group
was completely normalized at the end of the study and
was significantly higher compared to the HSB group. The
hemodynamic effects of lactate seemed to be related to
improvement in cardiac function rather than changes in
vascular tone. In fact, SVR was not significantly modified
by lactate administration. Moreover, the CI was slightly
higher in the group receiving lactate as has already been
observed [19]. It is known that lactate improves cardiac
efficiency during shock [32,33], and it has been shown that
lactate deprivation during shock impairs heart metabolism
[34]. Despite the fact that hypertonic fluids contained the
same amounts of sodium, HSB and HSL were different in
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as a key metabolic substrate under stress conditions
[35,36]. Furthermore, P(v-a)CO2 gradient was significantly
lower and skin blood flow, at rest and during hyperemia,
was significantly better in HSL group, suggesting better
tissue perfusion. Hypertonic fluids are known to reduce
microvascular collapse, restoring vital nutritional blood
flow and tending to blunt the upregulation of leukocyte
and endothelial adhesion molecules [37]. The improve-
ment of microcirculation in the HSL group compared to
the HSB group could be the result of an overall improve-
ment in global perfusion (MAP), and maybe an intrinsic
effect of lactate that remains to be explored.
One remarkable result of this study was the concur-
rent improvement of hemodynamic status and plasma
volume expansion in the HSL group, whereas fluid bal-
ance was negative. The higher volume of urine output in
the HSL group reflected an improvement in renal perfu-
sion that could be explained by better macro- and
microcirculatory status. Moreover, we observed a posi-
tive sodium balance associated with a negative chloride
balance following HSL infusion, which supports chloride
urine excretion coupled to the high sodium urine ex-
cretion. In fact, the important amount of urinary sodium
excretion creates an imbalance between positive and nega-
tive charges. As the urine is poor in protein (positive
charges could be neutralized by the increase of negative
charges on protein), a net anion efflux must therefore
compensate the excess of positive charges in order to
maintain electroneutrality. This is achieved for a substan-
tial part by an increase of urinary chloride excretion
[38,39]. Chloride, the principal intracellular inorganic
anion, is responsible for intracellular tonicity; hence the
net efflux of chloride could be accompanied by a net flux
of water [40]. This could participate to the larger urine
output with HSL infusion. This finding is noteworthy be-
cause it is generally difficult to achieve a negative fluid bal-
ance in the early phase of septic shock. Reducing fluid
overload and edema are always regarded as having positive
effects because of their link with organ dysfunction [6,10].
In a previous study in the same animal model, histologic
findings supported the development of respiratory distress
syndrome with marked pulmonary leukocyte seques-
tration and interstitial edema [26]. In our study, the
negative fluid balance in the lactate group was associ-
ated with improved PaO2/FiO2 ratio. This was con-
sistent with a previous human study on conservative
strategy of fluid management [8]. Finallyt, as already
described [41], the development of hypoglycemia in
porcine endotoxic shock could be due to a peak in
the insulin level at 90 minutes. Stability in blood glucose
levels in the animals receiving HSL was anticipated be-
cause lactate is a good precursor for glucose through liver
gluconeogenesis.Our model was stable with no hemodynamic varia-
tions during the stabilization period. We observed that
HSL resulted in significant improvements despite the
small numbers of animals per group. This suggests an
important effect of HSL. Hence, two main mechanisms
could be advanced to explain this effect: exogenous
lactate infusion is beneficial as an energy supplier and
the resulting sodium/chloride imbalance may induce a
negative fluid balance. However, our model presented
some limits: the short duration (five hours only, so
that there was little time for activation of the NO system);
administration of an LPS bolus rather than continuous
intravenous administration (bolus produces much more
severe acute pulmonary hypertension and eventually right
ventricular failure); and hypodynamic shock with inad-
equate resuscitation, whereas hyperdynamic shock is more
common in the ICU. Moreover, we observed predictable
side effects of HSL with hypernatremia and metabolic
alkalosis. It should be more suitable to use half molar
sodium lactate or to decrease the dose of 11.2% HSL
in order to limit the increase in sodium and bicar-
bonate levels. Furthermore, infusion of such a large
amount of lactate will modify the serum lactate level
and kinetics, and will have to be taken into account
in interpreting lactate monitoring during the initial
resuscitation. Last, if HSL was better that HSB due to
lactate metabolism, it would be interesting to add an-
other energy substrate (glucose for example) to HSB
in future experiments.
Conclusion
HSL can be used as an energy substrate and resuscitative
fluid. In our hypodynamic model of endotoxic shock,
HSL infusion improved hemodynamic stability and
microvascular reactivity with a negative fluid balance
and better oxygenation. Further investigations are war-
ranted to assess the potential clinical benefits of this
treatment.
Key messages
 Lactate is an interesting energetic substrate
that is well-metabolized even in poor
hemodynamic conditions and hypertonic
sodium lactate can be used as a resuscitative
fluid.
 In our porcine model of endotoxic shock,
infusion of hypertonic sodium lactate improves
hemodynamics and microcirculation with
a negative fluid balance and better
oxygenation.
 The resulting sodium/chloride imbalance with
hypertonic sodium lactate may induce a negative
fluid balance.
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